OSAM
ONC

O'Shaughnessy Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

O'Shaughnessy Asset Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$646K Sell
2,268
-376
-14% -$111K ﹤0.01% 1474
2026
Q1 		$785K Buy
2,644
+255
+11% +$82.5K ﹤0.01% 1306
2025
Q4 		$726K Buy
2,389
+359
+18% +$118K ﹤0.01% 1307
2025
Q3 		$692K Buy
2,030
+661
+48% +$201K ﹤0.01% 1309
2025
Q2 		$331K Buy
1,369
+115
+9% +$28.2K ﹤0.01% 1584
2025
Q1 		$341K Buy
1,254
+43
+4% +$10.1K ﹤0.01% 1510
2024
Q4 		$224K Buy
1,211
+216
+22% +$44.1K ﹤0.01% 1683
2024
Q3 		$226K Buy
+995
New +$179K ﹤0.01% 1621
2021
Q4 		– Sell
-70
Closed -$25K – 2561
2021
Q3 		$25K Buy
70
+47
+204% +$15.4K ﹤0.01% 1881
2021
Q2 		$8K Buy
23
+1
+5% +$331 ﹤0.01% 2059
2021
Q1 		$8K Sell
22
-21
-49% -$6.95K ﹤0.01% 1837
2020
Q4 		$11K Buy
43
+33
+330% +$9.09K ﹤0.01% 1541
2020
Q3 		$3K Buy
10
+7
+233% +$1.65K ﹤0.01% 1601
2020
Q2 		$1K Buy
+3
New +$488 ﹤0.01% 1680
2019
Q1 		– Sell
-46
Closed -$6K – 1022
2018
Q4 		$6K Buy
+46
New +$6.1K ﹤0.01% 815

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

O'Shaughnessy Asset Management's ONC Position: Q2 2026 in Review

O'Shaughnessy Asset Management reduced its BeOne Medicines Ltd (ONC) stake by 14% in Q2 2026, selling an estimated $111K and leaving 2,268 shares worth $646K. The position accounts for ﹤0.01% of the portfolio, ranked #1474.

O'Shaughnessy Asset Management first reported a position in ONC in Q4 2018 and has held it in 15 quarters since. The position peaked at $785K in Q1 2026. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • O'Shaughnessy Asset Management held 2,268 shares of BeOne Medicines Ltd worth $646K as of Q2 2026.
  • O'Shaughnessy Asset Management sold 376 BeOne Medicines Ltd shares in Q2 2026, an estimated $111K.
  • BeOne Medicines Ltd made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #1474 holding.
  • O'Shaughnessy Asset Management first reported a position in BeOne Medicines Ltd in Q4 2018 and has held it in 15 quarters since.
  • O'Shaughnessy Asset Management's BeOne Medicines Ltd position peaked at $785K in Q1 2026.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.